Statera Biopharma Inc (STAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,777 | 14,359 | 594 | 2,721 | 3,409 |
| Marketable Securities | N/A | 264 | N/A | 314 | 357 |
| Receivables | N/A | N/A | N/A | 135 | 247 |
| Other current assets | 47 | 70 | 332 | 55 | 57 |
| TOTAL | $13,824 | $14,694 | $926 | $3,225 | $4,070 |
| Non-Current Assets | |||||
| PPE Net | 5 | 6 | 9 | 6 | 9 |
| Other Non-Current Assets | 0 | 0 | 101 | 0 | 0 |
| TOTAL | $5 | $6 | $110 | $6 | $9 |
| Total Assets | $13,829 | $14,700 | $1,036 | $3,231 | $4,079 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 61 | 310 | 2,688 | 281 | 302 |
| Accrued Expenses | 240 | 208 | N/A | 197 | 486 |
| TOTAL | $301 | $518 | $4,621 | $484 | $787 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 7 | N/A |
| Other Non-Current Liabilities | 0 | 0 | 70 | 0 | 7 |
| TOTAL | $N/A | $N/A | $70 | $N/A | $N/A |
| Total Liabilities | $301 | $518 | $4,691 | $484 | $787 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 15,479 | 15,469 | 15,469 | 13,336 | 13,016 |
| Common Shares | 77 | 77 | 161 | 65 | 64 |
| Retained earnings | -170,302 | -169,642 | -27,763 | -168,409 | -167,664 |
| Other shareholders' equity | 4,277 | 4,271 | 0 | 4,327 | 4,388 |
| TOTAL | $13,528 | $14,182 | $-3,656 | $2,747 | $3,292 |
| Total Liabilities And Equity | $13,829 | $14,700 | $1,036 | $3,231 | $4,079 |